Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)

Clinical trial NCT02385721 · COMPLETED

Trial details

NCT number: NCT02385721
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Study type: OBSERVATIONAL

Essential Hypertension

Start date: 2013-05-01
Primary completion: 2017-07-01
Enrollment: 601

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.